Mehraboon Irani, Nirmal Bang Securities is of the view that one can buy Glenmark Pharma.
Irani told CNBC-TV18, "I think Lupin is one thing which attracts our attention. Sun Pharma has become relatively very expensive to the overall pharmaceutical bunch. So on declines again it will come out as a prime pick."
He further added, "Glenmark Pharma in the midcaps is definitely a good buy, but the stock has run up and has outperformed over the last one-one and half month. Maybe a decline over there would possibly attract our attention again."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
